Editorial: Augmentation therapy in alpha-1 antitrypsin deficiency

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 3, 2009, Pages 147-148

  Sandhaus, Robert A ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUGMENTATION THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EDITORIAL; HUMAN; INFUSION SYSTEM; LUNG DISEASE; LUNG FUNCTION; PRIORITY JOURNAL; CANADA; NOTE; PREVALENCE;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CANADA; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 70350455493     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550902976483     Document Type: Editorial

References (4)

1. Chapman KR, Stockley RA, Dawkins C, Wilkes MM, and Navickis RJ. Augmentation therapy for á 1-antitrypsin deficiency. A meta-analysis. JCOPD 2009.
2. Vreim CE, Wu M, Crystal RG, Buist AS, Burrows B, Cohen AB, et al. Survival and FEV1 decline in individuals with severe deficiency of a1-antitrypsin. Am J Respir Crit Care Med 1998; 158(1):49-59.
3. Wencker M, Banik N, Buhl R, Seidel R, and Konietzko N. Long-term treatment of alpha1-antitrypsin deficiencyrelated pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1- AT-study group. Eur Respir J 1998; 11(2):428-433.
4. Charlie Strange, principal investigator, QUANTUM-1 study (QUANTitative chest computed tomography UnMasking emphysema progression in alpha-1 antitrypsin deficiency) of the NIH Rare Lung Disease Consortium, personal communication, April 13, 2009.